Medicare Enrolled
Dr. Michael Lin, MD
Dermatology · Sherman Oaks, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lin
Dr. Michael Lin is a dermatology specialist in Sherman Oaks, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lin performed 14,094 Medicare services across 1,582 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lin received a total of $29,253 from 55 pharmaceutical and/or device companies across 757 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in CA
$29,253 industry payments
Medicare Practice Summary
Medicare Utilization ↗14,094
Medicare services
Top 5% in CA for dermatology
1,582
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~742 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Photodynamic therapy gel for precancerous skin | 11,400 | $1 | $3 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
526 | $6 | $14 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
526 | $74 | $166 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
481 | $103 | $242 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
190 | $50 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
159 | $121 | $364 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
138 | $80 | $230 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
99 | $20 | $54 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
97 | $76 | $242 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
95 | $98 | $256 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
94 | $148 | $346 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
56 | $259 | $604 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
49 | $577 | $1,520 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
31 | $42 | $156 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
26 | $106 | $276 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
25 | $45 | $124 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 22 | $62 | $150 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
22 | $113 | $300 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 19 | $372 | $908 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $46 | $102 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
12 | $91 | $288 |
| Shaving of skin growth on face, 0.6-1.0 cm This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters. |
11 | $123 | $312 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$29,253
Total received (2018-2024)
Avg $4,179/year across 7 years
Top 9% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
757
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,043 (61.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,998 (23.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,212 (14.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,125
2023
$4,079
2022
$2,305
2021
$1,634
2020
$719
2019
$8,992
2018
$5,400
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
STRATA Skin Sciences, Inc.
$1,506
ABBVIE INC.
$777
Organogenesis Inc.
$774
GENZYME CORPORATION
$473
E.R. Squibb & Sons, L.L.C.
$359
Janssen Biotech, Inc.
$351
Amgen Inc.
$283
UCB, Inc.
$266
Lilly USA, LLC
$248
Novartis Pharmaceuticals Corporation
$194
PFIZER INC.
$187
REVANCE THERAPEUTICS, INC.
$141
Incyte Corporation
$129
SUN PHARMACEUTICAL INDUSTRIES INC.
$90
Arcutis Biotherapeutics, Inc.
$62
Biofrontera Inc.
$51
LEO Pharma Inc.
$48
Verrica Pharmaceuticals Inc.
$41
Galderma Laboratories, L.P.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Regeneron Healthcare Solutions, Inc.
$28
Smith+Nephew, Inc.
$26
Medtronic, Inc.
$21
MAYNE PHARMA COMMERCIAL LLC
$9
Top 3 companies account for 49.9% of 2024 payments
All-time payments by company (2018-2024) ›
Apyx Medical Corporation
$6,998
iCAD, Inc
$3,684
ABBVIE INC.
$2,296
STRATA Skin Sciences, Inc.
$1,556
Organogenesis Inc.
$1,115
GENZYME CORPORATION
$1,038
Janssen Biotech, Inc.
$1,033
Novartis Pharmaceuticals Corporation
$1,026
Biofrontera Inc.
$942
Lilly USA, LLC
$927
PFIZER INC.
$923
Amgen Inc.
$898
Sun Pharmaceutical Industries Inc.
$741
UCB, Inc.
$585
AbbVie Inc.
$501
Allergan Inc.
$457
Merz North America, Inc.
$404
E.R. Squibb & Sons, L.L.C.
$398
Incyte Corporation
$367
AbbVie, Inc.
$334
Allergan, Inc.
$318
Galderma Laboratories, L.P.
$298
Vascular Insights, LLC
$267
Celgene Corporation
$263
SUN PHARMACEUTICAL INDUSTRIES INC.
$232
Bard Peripheral Vascular, Inc.
$226
Arcutis Biotherapeutics, Inc.
$173
REVANCE THERAPEUTICS, INC.
$141
LEO Pharma Inc.
$133
Regeneron Healthcare Solutions, Inc.
$106
Boehringer Ingelheim Pharmaceuticals, Inc.
$86
DUSA Pharmaceuticals, Inc.
$83
Ortho Dermatologics, a division of Bausch Health US, LLC
$79
Almirall LLC
$69
DERMIRA, INC.
$66
SANOFI-AVENTIS U.S. LLC
$46
Verrica Pharmaceuticals Inc.
$41
Medtronic, Inc.
$39
Boston Scientific Corporation
$33
Mylan Pharmaceuticals Inc.
$30
EPI Health, LLC
$29
Smith+Nephew, Inc.
$26
Taro Pharmaceuticals USA, Inc.
$24
ORGANOGENESIS INC.
$24
Genentech USA, Inc.
$23
Encore Dermatology Inc.
$22
Dermavant Sciences, Inc.
$22
Phadia US Inc.
$22
Journey Medical Corporation
$20
Medimetriks Pharmaceuticals, Inc.
$20
BOSTON SCIENTIFIC CORPORATION
$19
Mayne Pharma Inc.
$15
TARO PHARMACEUTICALS USA, INC.
$13
PruGen, Inc. Pharmaceuticals
$13
MAYNE PHARMA COMMERCIAL LLC
$9
Top 3 companies account for 44.4% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA LD · ACCURIAN · ADBRY · AFFINITY · AKLIEF · AMELUZ · Absorica LD · Ameluz · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · CYGNUS DUAL · CYLTEZO · Cimzia · Clarivein · DAXXIFY · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EUCRISA · Enbrel · Erivedge · GENERAL - VASCULAR INTERVENTION · GRAFIX · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · ImmunoCAP · Impoyz · KYBELLA · Klisyri · LEVULAN KERASTICK · LIBTAYO · NUSHIELD · Neo-Synalar · OPZELURA · ORACEA · Olux · Otezla · Puraply · QBREXZA · RINVOQ · RotarexS 6 F x 135 cm · SILIQ · SKYRIZI · SPEVIGO · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · Tremfya · ULTRAVATE · ULTRAVATE (halobetasol propionate) lotion · Ultraverse 014 · VTAMA · Varithena Administration Pack · Venclose Maven Catheter · Winlevi · XEOMIN · XTRAC · Xeomin · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for dermatology in CA.
Geographic Context
Dermatologists within 10 mi
441
Per 100K population
4.5
County median income
$87,760
Nearest hospital
SHERMAN OAKS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lin is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement in the top 9% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lin experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Lin performed 11,400 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lin receive payments from pharmaceutical companies?
Yes. Dr. Lin received a total of $29,253 from 55 companies across 757 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lin's costs compare to other dermatologists in Sherman Oaks?
Dr. Lin's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Sherman Oaks
Browse dermatologists in Sherman Oaks ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in CA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in CA
Which CA dermatologists receive the most from drug and device companies.
By company
Apyx Medical Corporation Payments to Doctors
See all physicians who received payments from Apyx Medical Corporation.
By company
iCAD, Inc Payments to Doctors
See all physicians who received payments from iCAD, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology